COVID-19 vaccination: Janssen vaccine

The Health Council of Netherlands recommends that the Janssen vaccine be incorporated into the current vaccination strategy, which prioritises groups with the highest risk of severe morbidity and mortality from COVID-19. This primarily concerns older adults aged sixty and above. The Council recommends that the sequence of vaccination for this group should be from old to young. It has also focused on groups with specific medical conditions, such as individuals with Down syndrome, those with morbid obesity (severe overweight, a body mass index in excess of 40) and patients with neurological disorders that can lead to respiratory problems.